| ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications C Maaser, A Sturm, SR Vavricka, T Kucharzik, G Fiorino, V Annese, ... Journal of Crohn's and Colitis 13 (2), 144-164K, 2019 | 1422 | 2019 |
| Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines J Panes, Y Bouhnik, W Reinisch, J Stoker, SA Taylor, DC Baumgart, ... Journal of Crohn's and Colitis 7 (7), 556-585, 2013 | 764 | 2013 |
| Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn’s disease G Monteleone, MF Neurath, S Ardizzone, A Di Sabatino, MC Fantini, ... New England Journal of Medicine 372 (12), 1104-1113, 2015 | 486 | 2015 |
| Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ... Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011 | 389 | 2011 |
| ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects A Sturm, C Maaser, E Calabrese, V Annese, G Fiorino, T Kucharzik, ... Journal of Crohn's and Colitis 13 (3), 273-284, 2019 | 371 | 2019 |
| Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ... Gut 69 (7), 1213-1217, 2020 | 357 | 2020 |
| A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Cancer of the Liver Italian Program (CLIP) Investigators Hepatology 28 (3), 751-755, 1998 | 356 | 1998 |
| European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] ECCO-ESGAR Guideline for Diagnostic Assessment in … C Maaser, A Sturm, SR Vavricka, T Kucharzik, G Fiorino, V Annese, ... J Crohns Colitis 13 (2), 144-164, 2019 | 279 | 2019 |
| Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo‐controlled trial with rifaximin C Prantera, H Lochs, M Campieri, ML Scribano, GC Sturniolo, ... Alimentary pharmacology & therapeutics 23 (8), 1117-1125, 2006 | 215 | 2006 |
| The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women N Pedersen, A Bortoli, D Duricova, R D′ Inca, MR Panelli, JP Gisbert, ... Alimentary pharmacology & therapeutics 38 (5), 501-512, 2013 | 209 | 2013 |
| Pregnancy outcome in inflammatory bowel disease: prospective European case‐control ECCO‐EpiCom study, 2003–2006 A Bortoli, N Pedersen, D Duricova, R D′ Inca, P Gionchetti, MR Panelli, ... Alimentary pharmacology & therapeutics 34 (7), 724-734, 2011 | 201 | 2011 |
| Prospective validation of the CLIP score: a new prognostic system for patient with cirrhosis and hepatocellular carcinoma F Izzo, O Cuomo, G Capuano, G Ruggiero, R Mazzanti, F Farinati, ... Hepatology 31, 840-845, 2000 | 197 | 2000 |
| Helicobacter pylori impairs iron absorption in infected individuals C Ciacci, F Sabbatini, R Cavallaro, F Castiglione, S Di Bella, P Iovino, ... Digestive and liver disease 36 (7), 455-460, 2004 | 196 | 2004 |
| Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study L Biancone, A Orlando, A Kohn, E Colombo, R Sostegni, E Angelucci, ... Gut 55 (2), 228-233, 2006 | 181 | 2006 |
| Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn's disease: the SuPREMe-CD study-a randomized clinical trial G Luglio, A Rispo, N Imperatore, MC Giglio, A Amendola, FP Tropeano, ... Annals of surgery 272 (2), 210-217, 2020 | 171 | 2020 |
| Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease F Castiglione, A Rispo, E Di Girolamo, A Cozzolino, F Manguso, ... Alimentary pharmacology & therapeutics 18 (11‐12), 1107-1112, 2003 | 158 | 2003 |
| One‐year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing F Castiglione, N Imperatore, A Testa, GD De Palma, OM Nardone, ... Alimentary pharmacology & therapeutics 49 (8), 1026-1039, 2019 | 154 | 2019 |
| Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. F Castiglione, S Pignata, F Morace, A Sarubbi, MA Baratta, L D'Agostino, ... The Italian journal of gastroenterology 28 (4), 199-204, 1996 | 147 | 1996 |
| Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial CLIP group The Lancet 352 (9121), 17-20, 1998 | 141 | 1998 |
| Noninvasive diagnosis of small bowel Crohn’s disease: direct comparison of bowel sonography and magnetic resonance enterography F Castiglione, PP Mainenti, GD De Palma, A Testa, L Bucci, G Pesce, ... Inflammatory bowel diseases 19 (5), 991-998, 2013 | 140 | 2013 |
